Evidence map›Paper›PMID 26010861›Full record

Trial reportPsychoneuroendocrinology2015

Distinct cognitive effects of estrogen and progesterone in menopausal women.

Alison Berent-Spillson, Emily Briceno, Alana Pinsky, Angela Simmen, Carol C Persad, Jon-Kar Zubieta, Yolanda R Smith

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychoneuroendocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Longitudinal untargeted metabolomics of cognitive impairment in Parkinson's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Associations between reproductive history, hormone use,Frontiers in aging neuroscience · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alison Berent-SpillsonUniversity of Michigan, Psychiatry Department, MBNI, 205 Zina Pitcher Place, Ann Arbor, MI 48109, USA. Electronic address: berent@umich.edu.
Emily BricenoUniversity of Michigan, Psychiatry Department, Neuropsychology Division, 2101 Commonwealth Blvd, Suite C, Ann Arbor, MI 48105, USA. Electronic address: emilande@umich.edu.
Alana PinskyUniversity of Michigan Medical School, 1301 Catherine, Ann Arbor, MI, 48109, USA. Electronic address: apinksy@umich.edu.
Angela SimmenUniversity of Michigan, Obstetrics and Gynecology Department, L4000 Womens SPC, 1500 E. Medical Center Dr, Ann Arbor, MI, 48109, USA. Electronic address: asimmen@med.umich.edu.
Carol C PersadUniversity of Michigan, Psychiatry Department, Neuropsychology Division, 2101 Commonwealth Blvd, Suite C, Ann Arbor, MI 48105, USA. Electronic address: cpersad@umich.edu.
Jon-Kar ZubietaUniversity of Michigan, Psychiatry Department, MBNI, 205 Zina Pitcher Place, Ann Arbor, MI 48109, USA. Electronic address: zubieta@umich.edu.
Yolanda R SmithUniversity of Michigan, Obstetrics and Gynecology Department, L4000 Womens SPC, 1500 E. Medical Center Dr, Ann Arbor, MI, 48109, USA. Electronic address: ysmith@umich.edu.
University of Michigan · US

Funding

Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
Endogenous opioid activity and affective state in insulin resistant womenK01MH095920 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BERENT-SPILLSON, ALISON RENEE · 2013 to 2017
$707k
Hormones and cognitive processing in early postmenopausal womenR21AG031951 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SMITH, YOLANDA R · 2009 to 2010
$360k
NCATS NIH HHS UL1 TR000433NIA NIH HHS R21 AG031951NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK092926NIMH NIH HHS K01 MH095920
6 · The paper itself

Abstract

The effects of postmenopausal hormone treatment on cognitive outcomes are inconsistent in the literature. Emerging evidence suggests that cognitive effects are influenced by specific hormone formulations, and that progesterone is more likely to be associated with positive outcomes than synthetic progestin. There are very few studies of unopposed progesterone in postmenopausal women, and none that use functional neuroimaging, a sensitive measure of neurobiological function. In this study of 29 recently postmenopausal women, we used functional MRI and neuropsychological measures to separately assess the effects of estrogen or progesterone treatment on visual and verbal cognitive function. Women were randomized to receive 90 days of either estradiol or progesterone counterbalanced with placebo. After each treatment arm, women were given a battery of verbal and visual cognitive function and working memory tests, and underwent functional MRI including verbal processing and visual working memory tasks. We found that both estradiol and progesterone were associated with changes in activation patterns during verbal processing. Compared to placebo, women receiving estradiol treatment had greater activation in the left prefrontal cortex, a region associated with verbal processing and encoding. Progesterone was associated with changes in regional brain activation patterns during a visual memory task, with greater activation in the left prefrontal cortex and right hippocampus compared to placebo. Both treatments were associated with a statistically non-significant increase in number of words remembered following the verbal task performed during the fMRI scanning session, while only progesterone was associated with improved neuropsychological measures of verbal working memory compared to placebo. These results point to potential cognitive benefits of both estrogen and progesterone.

Indexed as

AgedCognitionEstrogen Replacement TherapyEstrogensFemaleHumansMagnetic Resonance ImagingMemory, Short-TermMiddle AgedNeuropsychological TestsPlacebosPostmenopauseProgesteroneEstrogensPlacebosProgesteroneCognitionFunctional MRIMenopausePostmenopausal hormone treatmentProgesterone

Identifiers

PMID26010861
PMCPMC4490102
OpenAlexW1492024043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.